StockData
Innospec Inc. logo

Innospec Inc. (IOSP) stock

IOSPNasdaqChemicals & Allied ProductsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3016% below fair value
$78.86+0.85 (+1.09%)

Close on Nov 18, 2026Market cap $1.94BP/E –Yield 2.17%

Innospec operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Innospec's operating cash flow for the twelve months ending Jun 30, 2026 was $124.30M, down 9.9% year over year. For fiscal 2025 it was $138.30M, down 25.0% from the year before. Over ten years it grew 1.6% a year on average. The highest annual figure on record is $207.30M in fiscal 2023.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$138.30M-25.0%
FY2024Dec 31, 2024$184.50M-11.0%
FY2023Dec 31, 2023$207.30M+153.7%
FY2022Dec 31, 2022$81.70M-12.3%
FY2021Dec 31, 2021$93.20M-36.1%
FY2020Dec 31, 2020$145.90M-9.7%
FY2019Dec 31, 2019$161.60M+54.1%
FY2018Dec 31, 2018$104.90M+26.8%
FY2017Dec 31, 2017$82.70M-21.6%
FY2016Dec 31, 2016$105.50M-10.7%
FY2015Dec 31, 2015$118.20M+11.2%
FY2014Dec 31, 2014$106.30M+73.4%
FY2013Dec 31, 2013$61.30M0.0%
FY2012Dec 31, 2012$61.30M+76.7%
FY2011Dec 31, 2011$34.70M-40.4%
FY2010Dec 31, 2010$58.20M-33.4%
FY2009Dec 31, 2009$87.40M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$7.20M-31.4%
Q1 FY2026Mar 31, 2026$17.60M-37.8%
Q4 FY2025Dec 31, 2025$61.40M+138.9%
Q3 FY2025Sep 30, 2025$38.10M-48.2%
Q2 FY2025Jun 30, 2025$10.50M+123.4%
Q1 FY2025Mar 31, 2025$28.30M-64.9%
Q4 FY2024Dec 31, 2024$25.70M-64.5%
Q3 FY2024Sep 30, 2024$73.50M+26.5%
Q2 FY2024Jun 30, 2024$4.70M-91.5%
Q1 FY2024Mar 31, 2024$80.60M+269.7%
Q4 FY2023Dec 31, 2023$72.40M-7.7%
Q3 FY2023Sep 30, 2023$58.10M+46.0%
Q2 FY2023Jun 30, 2023$55.00M–
Q1 FY2023Mar 31, 2023$21.80M–
Q4 FY2022Dec 31, 2022$78.40M+14.0%
Q3 FY2022Sep 30, 2022$39.80M+1321.4%
Q2 FY2022Jun 30, 2022-$7.50M–
Q1 FY2022Mar 31, 2022-$29.00M-227.8%
Q4 FY2021Dec 31, 2021$68.80M+18.2%
Q3 FY2021Sep 30, 2021$2.80M-95.0%
Q2 FY2021Jun 30, 2021-$1.10M-103.7%
Q1 FY2021Mar 31, 2021$22.70M+845.8%
Q4 FY2020Dec 31, 2020$58.20M-0.3%
Q3 FY2020Sep 30, 2020$55.50M+38.7%
Q2 FY2020Jun 30, 2020$29.80M-40.4%
Q1 FY2020Mar 31, 2020$2.40M-81.8%
Q4 FY2019Dec 31, 2019$58.40M-16.3%
Q3 FY2019Sep 30, 2019$40.00M+14.9%
Q2 FY2019Jun 30, 2019$50.00M+2073.9%
Q1 FY2019Mar 31, 2019$13.20M–
Q4 FY2018Dec 31, 2018$69.80M+46.9%
Q3 FY2018Sep 30, 2018$34.80M-24.5%
Q2 FY2018Jun 30, 2018$2.30M-74.4%
Q1 FY2018Mar 31, 2018-$2.00M–
Q4 FY2017Dec 31, 2017$47.50M+156.8%
Q3 FY2017Sep 30, 2017$46.10M+54.2%
Q2 FY2017Jun 30, 2017$9.00M–
Q1 FY2017Mar 31, 2017-$19.90M–
Q4 FY2016Dec 31, 2016$18.50M–
Q3 FY2016Sep 30, 2016$29.90M–

More Innospec figures

See a number that looks wrong?